FDA Accepts Supplement for Labetalol Hydrochloride by Epic Pharma
The FDA has accepted a supplemental application for Labetalol Hydrochloride submitted by Epic Pharma.
Company
Pharmaceutical intelligence for Epic Pharma with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.